These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 8797600)

  • 1. Construction of phosphorylatable monoclonal antibody to a tumor-associated antigen.
    Lin L; Daugherty B; Schlom J; Pestka S
    Cancer Res; 1996 Sep; 56(18):4250-4. PubMed ID: 8797600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of phosphorylatable chimeric monoclonal antibody CC49 with a casein kinase I recognition site.
    Lin L; Gillies SD; Schlom J; Pestka S
    Protein Expr Purif; 1999 Feb; 15(1):83-91. PubMed ID: 10024474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of phosphorylatable monoclonal antibody CC49 with a casein kinase II recognition site.
    Lin L; Gillies SD; Schlom J; Pestka S
    Anticancer Res; 1998; 18(6A):3971-8. PubMed ID: 9891433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of phosphorylatable chimeric monoclonal antibody CC49.
    Lin L; Gillies SD; Lan Y; Izotova L; Wu W; Schlom J; Pestka S
    Int J Oncol; 1998 Jul; 13(1):115-20. PubMed ID: 9625812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The construction of a mouse/human chimeric antibody against human breast cancer cells.
    Meulemans E; Vandevyver C; Volckaert G; Raus J
    Year Immunol; 1993; 7():131-6. PubMed ID: 8372502
    [No Abstract]   [Full Text] [Related]  

  • 6. Construction of phosphorylatable chimeric monoclonal antibody CC49 with a tyrosine srC kinase recognition site.
    Lin L; Gillies SD; Schlom J; Pestka S
    Int J Oncol; 1998 Oct; 13(4):725-32. PubMed ID: 9735402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of a recombinant chimeric protein in which the gamma-carboxyglutamic acid and helical stack domains of human anticoagulant protein C are replaced by those of human coagulation factor VII.
    Geng JP; Castellino FJ
    Thromb Haemost; 1997 May; 77(5):926-33. PubMed ID: 9184404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer].
    Wang Y; Li X; Chen W
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan; 26(1):16-21. PubMed ID: 16495168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The AID antibody diversification enzyme is regulated by protein kinase A phosphorylation.
    Basu U; Chaudhuri J; Alpert C; Dutt S; Ranganath S; Li G; Schrum JP; Manis JP; Alt FW
    Nature; 2005 Nov; 438(7067):508-11. PubMed ID: 16251902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetically engineered single-gene-encoded anti-TAG72 chimeric antibody secreted from myeloma cells.
    Qi Y; Xiang J
    Hum Antibodies Hybridomas; 1995; 6(4):161-6. PubMed ID: 8688499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H; Arakawa F; Imakiire T; Kuroki M; Kuroki M
    Anticancer Res; 2003; 23(6a):4383-8. PubMed ID: 14666725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and construction of a phosphorylatable chimeric monoclonal antibody with a highly stable phosphate.
    Wu W; Kerrigan JE; Yadav P; Schwartz B; Izotova L; Lavoie TB; Pestka S
    Oncol Res; 2004; 14(11-12):541-58. PubMed ID: 15666996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Development of genetically engineered chimeric and single chain antibodies against human brain glioma: a preliminary report].
    Huang Q; Shen S; Xu Z
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):259-62. PubMed ID: 9387315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting gamma interferon to tumor cells by a genetically engineered fusion protein secreted from myeloma cells.
    Xiang J; Qi Y; Cook D; Moyana T
    Hum Antibodies Hybridomas; 1996; 7(1):2-10. PubMed ID: 8886831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
    Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular cloning of a tumor-associated antigen recognized by monoclonal antibody 3H11.
    Chen D; Shou C
    Biochem Biophys Res Commun; 2001 Jan; 280(1):99-103. PubMed ID: 11162484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved yield and stability of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation, by protein engineering.
    McDonagh CF; Beam KS; Wu GJ; Chen JH; Chace DF; Senter PD; Francisco JA
    Bioconjug Chem; 2003; 14(5):860-9. PubMed ID: 13129388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and purification of domain-deleted immunoglobulin variants of the recombinant/chimeric B72.3 (y1) monoclonal antibody.
    Calvo B; Kashmiri SV; Hutzell P; Hand PH; Slavin-Chiorini DC; Schlom J; Zaremba S
    Cancer Biother; 1993; 8(1):95-109. PubMed ID: 7529083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.